Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsAll products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-PTPRC DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
| Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
| DMAb-0158-YJ | SPM496 | Mouse | Human | IgG1, κ | Stimulated human leukocytes were used as the immunogen for the LCA antibody. | |
| DMAb-1879-WJ | A20 | Mouse | Mouse | IgG2a, κ | SJL mouse thymocytes and splenocytes | |
| DMAb-1880-WJ | B-A11 | Mouse | Human | IgG1 | Thymus cells and Jurkat cell line | |
| DMAb-1881-WJ | B-C15 | Mouse | Human | IgG1 | Reh 6 cell line | |
| DMAb-1882-WJ | BHKG-2 | Mouse | Human | IgG1 | ||
| DMAb-1883-WJ | BHPT-1 | Mouse | Human | IgG1 | Derived from the hybridization of mouse NS-1 myeloma cells with spleen cells of BALB/c mice immunized with peripheral blood monocytes from rheumatoid arthritis patient | |
| DMAb-1884-WJ | BRA-11 | Mouse | Human | IgG1, κ | Non-T, non-B CALLA positive ALL cell line REH (Leucocyte Workshop IV and V) | |
| DMAb-1885-WJ | Bu78 | Mouse | Human | IgG1 | ||
| DMAb-0955-LY | C11 | Mouse | Human | IgG2a, κ | ||
| DMAb-1887-WJ | C363.16A | Rat | IgG2a | Murine CD45RB | ||
| DMAb-1888-WJ | C455.1F | Rat | Mouse | IgG2a | ||
| DMAb-1889-WJ | CC1 | Mouse | IgG1 | |||
| DMAb-1890-WJ | CC76 | Mouse | Bovine | IgG1 | ||
| DMAb-1896-WJ | EM-05 | Rat | Mouse | IgG | ||
| DMAb-1897-WJ | F10-89-4 | Mouse | Human | IgG2a | ||
| DMAb-1898-WJ | F8-11-13 | Mouse | Human | IgG1 | ||
| DMAb-1900-WJ | GL24 | Rat | Mouse | IgM | Activated DBA/2 B cells | |
| DMAb-1902-WJ | HI100 | Mouse | Human | IgG2b, κ | ||
| DMAb-1903-WJ | HI30 | Mouse | Human | IgG1 | ||
| DMAb-1904-WJ | HIS24 | Mouse | Rat | IgG2b, κ | ||
| DMAb-1905-WJ | HIS41 | Mouse | Rat | IgG1 | ||
| DMAb-1907-WJ | I3/2.3 | Rat | IgG2b | CD45 antibody (Azide free) was raised in Rat using CD45/LCA as the immunogen | ||
| DMAb-1908-WJ | IBL-3/16 | Rat | Mouse | IgG1 | Purified B cells from mouse lymph nodes | |
| DMAb-1909-WJ | IBL-5/25 | Rat | Mouse | IgG1, κ | Mouse lymph node cells | |
| DMAb-1910-WJ | IBL-8 | Rat | Mouse | IgG1, κ | CD45RC (Mouse CD45RC) | |
| DMAb-1911-WJ | IH-1 | Mouse | Guinea Pig | IgG1 | Guinea pig leukemic B lymphocyte L2C cells | |
| DMAb-1912-WJ | IL-A116 | Mouse | Bovine | IgG | Bovine peripheral blood monouclear cells | |
| DMAb-1913-WJ | JS-83 | Mouse | Human | IgG1, κ | ||
| DMAb-1914-WJ | K252-1E4 | Mouse | Pig | IgG1 | ||
| DMAb-1916-WJ | LT40 | Mouse | Chicken | IgM | ||
| DMAb-1924-WJ | ANK74 | Mouse | Rat | IgG1 | IL-2-activated cultured NK cells of Wag rats | |
| DMAb-1931-WJ | BRA-55 | Mouse | Human | IgG1 | ||
| DMAb-1933-WJ | CA12.10C12 | Mouse | Dog | IgG1 | ||
| DMAb-1934-WJ | CA4.1D3 | Mouse | Canine | IgG1 | ||
| DMAb-1936-WJ | CDLA45RA-1 | Mouse | Human | IgG2a, κ | ||
| DMAb-1937-WJ | CDLA45RB-1 | Mouse | Human | IgG1, κ | ||
| DMAb-1938-WJ | CDLA45RO-1 | Mouse | Human | IgG2a, κ | ||
| DMAb-1946-WJ | UCH-L1 | Mouse | Human | IgG2a | IL-2-dependent T-cell line (CA1) | |
| DMAb-1950-WJ | DF-B1 | Mouse | Human | IgG3, κ | Extract from Alexanders hepatoma cell line L428 (Workshop V) | |
| DMAb-1951-WJ | E19-G | Rabbit | Human | IgG | Peptide derived from C-terminal sequence of human CD45 | |
| DMAb-1957-WJ | HB220 | Rat | Mouse | IgG2a | ||
| DMAb-1962-WJ | IVA103 | Mouse | Bovine | IgG1 | ||
| DMAb-1963-WJ | L12/201 | Mouse | Rabbit | IgG1 | Glycoproteins isolated from the T cell line, RL-5 | |
| DMAb-1965-WJ | LT45 | Mouse | Human | IgG2a | ||
| DMAb-1884-WJ | BRA-11 | Mouse | Human | IgG1, κ | ||
| DMAb-1897-WJ | F10-89-4 | Mouse | IgG2a, κ | Purified T cells from human lymph nodes | ||
| DMAb-1898-WJ | F8-11-13 | Mouse | IgG1 | Human T lymphocytes | ||
| DMAb-1902-WJ | HI100 | Mouse | Human | IgG2b, κ | The immunogen was CD45RA | |
| DMAb-1903-WJ | HI30 | Mouse | IgG1 | An amino acid sequence that is conserved among all CD45 isoforms | ||
| DMAb-1821-CQ | HLe-1(2D1) | Mouse | Human | IgG1 | Human peripheral blood mononuclear cells | |
| DMAb-1907-WJ | I3/2.3 | Rat | IgG2b | T1M1 (Thy-1--c) cells | ||
| DMAb-1823-CQ | MEM-143 | Mouse | Human | IgG1 | Human peripheral blood lymphocytes | |
| DMAb-1824-CQ | MEM-28 | Mouse | IgG1 | Human thymocytes and T lymphocytes | ||
| DMAb-1825-CQ | MEM-56 | Mouse | Human | IgG2b | Human thymocytes and T lymphocytes | |
| DMAb-1826-CQ | PD7/26 | Mouse | Human | IgG1, κ | Human peripheral blood lymphocytes maintained in T cell growth factor | |
| DMAb-1827-CQ | PTPRC/1132 | Mouse | Human | IgG1, κ | Recombinant Full length human CD45RB protein | |
| DMAb-1828-CQ | PTPRC/1147 | Mouse | Human | IgG1, κ | Recombinant Full length human CD45RB protein | |
| DMAb-1829-CQ | SPM125 | Mouse | IgG2a, κ | Cultured human T-cells from an IL-2-dependent T-cell line (CA1) | ||
| DMAb-0158-YJ | SPM496 | Mouse | Human | IgG1, κ | Stimulated human leukocytes | |
| DMAb-1831-CQ | SPM568 | Mouse | Human | IgG2a, κ | Stimulated human leukocytes | |
| DMAb-1832-CQ | SPM569 | Mouse | Human | IgG1, κ | Human peripheral blood lymphocytes maintained in T cell growth factor | |
| DMAb-1833-CQ | SPM570 | Mouse | Human | IgG1, κ | Isolated neoplastic cells from T cell lymphoma | |
| DMAb-1834-CQ | T200/797 | Mouse | Human | IgG2a, κ | Recombinant human CD45RO protein | |
| DMAb-1835-CQ | UCHL1 | Mouse | IgG2a, κ | Interleukin-2-dependent human T lymphocytes | ||
| DMAb-1836-CQ | X148 | Mouse | Human | IgG | T cell lymphoma cells | |
| DMAb-1837-CQ | X16 | Mouse | Human | IgG1 | T cell Lymphoma cells | |
| DMAb-1838-CQ | YTH24.5 | Rat | Human | IgG2b | Human T lymphocytes | |
| DMAb-1839-CQ | T6D11 | Mouse | IgG2b | |||
| DMAb-1840-CQ | MEM-55 | Mouse | Human | IgG1 | ||
| DMAb-1841-CQ | Bra55 | Mouse | Human | IgG1 | ||
| DMAb-0955-LY | C11 | Mouse | Human | IgG2a, κ | Human lymphocytes | |
| DMAb-1950-WJ | DF-B1 | Mouse | Human | IgG3, κ | Extract from Alexanders hepatoma cell line L428 | |
| DMAb-1844-CQ | hCD45 | Mouse | Human | IgG2a | ||
| DMAb-1845-CQ | YAML 501.4 | Rat | Human | IgG2a | ||
| DMAb-1849-CQ | YW62.3 | Rat | Mouse | IgG2b | Mouse spleen cells | |
| DMAb-1850-CQ | C363-16A | Rat | Mouse | IgG2a, κ | Cloned mouse Th2 cell lines | |
| DMAb-1851-CQ | PAN-LCA | Mouse | Human | IgG | ||
| DMAb-1852-CQ | 135-4C5 | Mouse | Human | IgG2b, κ | Stimulated human leukocytes | |
| DMAb-1853-CQ | PTPRC/1460 | Mouse | Human | IgG1, κ | Human B lymphocytes for the CD45 antibody | |
| DMAb-1885-WJ | Bu78 | Mouse | Human | IgG1 | ||
| DMAb-1913-WJ | JS-83 | Mouse | Human | IgG1, κ | The immunogen was CD45RA | |
| DMAb-1856-CQ | 111-1C5 | Mouse | Human | IgG1, κ | Stimulated human leukocytes | |
| DMAb-1857-CQ | YTH 80.103 | Rat | Human | IgG2b | ||
| DMAb-M302-YC | 5 | Mouse | Human | IgG1 | Recombinant Human CD45 protein | |
| DMAb-M303-YC | 104 | Mouse | Mouse | IgG2a | ||
| DMAb-0180-CN | OX-1 | Mouse | Rat | IgG1 | Rat thymocyte membrane glycoproteins. | |
| DMAb-0181-CN | OX-33 | Mouse | Rat | IgG1 | Purified Rat spleen CD45RA | |
| DMAb-1850-CQ | C363-16A | Rat | Mouse | IgG2a | Cloned mouse Th2 cell lines | |
| DMAb-1823-CQ | MEM-143 | Mouse | Human | IgG1 | Tissue/cell preparation (Human). Peripheral blood lymphocytes | |
| DMAb-1840-CQ | MEM-55 | Mouse | IgG1 | |||
| DMAb-0185-CN | OX-22 | Mouse | Rat | IgG1 | PHA stimulated rat lymphocytes | |
| DMAb-1835-CQ | UCHL1 | Mouse | Human | IgG2a | Human IL-2 dependent T cells |
There are currently no customer reviews or questions for Anti-PTPRC DNA-encoded mAb (DMAb), pVAX1 (DMAb-0158-YJ). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
